Main Topic Area
All Topic Areas
1 - 10 of 939 more >>
Articles
1 - 1 of 1
- Antagon Injection Consumer Information
Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely...
U.S. Food and Drug Administration
News
1 - 5 of 304 more >>
- Injection Drug Use Fueling Spread Of HIV In Mauritius
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
- FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- International Narcotics Control Board Hindering HIV/AIDS Control Efforts, Should Be Independently Reviewed, Report Says
MedicalNewsToday - Mon, 05 Mar 2007 12:00 EST
- More Frequent Participation In Needle-Exchange Programs Does Not Increase Risk Of HIV Infection, Study Says
MedicalNewsToday - Fri, 02 Mar 2007 06:00 EST
- New Storage Instructions Approved For BYETTA®
MedicalNewsToday - Sun, 25 Feb 2007 08:00 EST
Clinical Trials
1 - 5 of 312 more >>
- Combination Bisphosphonate and Anti-Angiogenesis Therapy with Pamidronate and Thalidomide
ClinicalTrials.gov Identifier: NCT00083382 - Active, not recruiting
Multiple Myeloma
- Pamidronate to Treat Osteogenesis Imperfecta in Children
ClinicalTrials.gov Identifier: NCT00005901 - Recruiting
Osteogenesis Imperfecta
- Neoadjuvant and Adjuvant Pamidronate With Induction and Maintenance Chemotherapy in Treating Patients With Osteosarcoma
ClinicalTrials.gov Identifier: NCT00072306 - Active, not recruiting
localized osteosarcoma; metastatic osteosarcoma
- A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
ClinicalTrials.gov Identifier: NCT00101790 - Recruiting
Low Back Pain
- Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
ClinicalTrials.gov Identifier: NCT00164008 - Active, not recruiting
Osteopenia; Heart Transplantation; Lung Transplantation

Not Signed In -

